Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thilo Werner

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Nature Biotechnology|January 22, 2020
Identifying drug targets in tissues and whole blood with thermal-shift profilingJessica Perrin, Thilo Werner, Nils Kurzawa, et al.
Cell|March 20, 2018
Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein HomeostasisMikhail M Savitski, Nico Zinn, Maria Faelth-Savitski, et al.
Science (New York, N.Y.)|June 17, 2017
Click chemistry enables preclinical evaluation of targeted epigenetic therapiesDean S Tyler, Johanna Vappiani, Tatiana Cañeque, et al.
Cancer Research Communications|July 19, 2024
Synergistic Effects of PARP Inhibition and Cholesterol Biosynthesis Pathway ModulationAnna Rutkowska, H Christian Eberl, Thilo Werner, et al.
Nature Communications|April 7, 2026
Alpibectir-Ethionamide combination (AlpE) for the treatment of tuberculosisZainab Edoo, Camille Grosse, Thomas Maitre, et al.
Science (New York, N.Y.)|March 21, 2020
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammationOmer Gilan, Inmaculada Rioja, Kathy Knezevic, et al.
Cancer Discovery|April 8, 2024
Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer CellsGabriele Picco, Yanhua Rao, Angham Al Saedi, et al.
Journal of Medicinal Chemistry|August 13, 2024
Discovery of Potent STT3A/B Inhibitors and Assessment of Their Multipathogen Antiviral Potential and SafetyJoseph E Pero, Elizabeth A Mueller, Ashley M Adams, et al.
Nature Cancer|November 18, 2021
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemiaMelissa B Pappalardi, Kathryn Keenan, Mark Cockerill, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Nature Biotechnology|January 22, 2020
Identifying drug targets in tissues and whole blood with thermal-shift profilingJessica Perrin, Thilo Werner, Nils Kurzawa, et al.
Cell|March 20, 2018
Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein HomeostasisMikhail M Savitski, Nico Zinn, Maria Faelth-Savitski, et al.
Science (New York, N.Y.)|June 17, 2017
Click chemistry enables preclinical evaluation of targeted epigenetic therapiesDean S Tyler, Johanna Vappiani, Tatiana Cañeque, et al.
Cancer Research Communications|July 19, 2024
Synergistic Effects of PARP Inhibition and Cholesterol Biosynthesis Pathway ModulationAnna Rutkowska, H Christian Eberl, Thilo Werner, et al.
Nature Communications|April 7, 2026
Alpibectir-Ethionamide combination (AlpE) for the treatment of tuberculosisZainab Edoo, Camille Grosse, Thomas Maitre, et al.
Science (New York, N.Y.)|March 21, 2020
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammationOmer Gilan, Inmaculada Rioja, Kathy Knezevic, et al.
Cancer Discovery|April 8, 2024
Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer CellsGabriele Picco, Yanhua Rao, Angham Al Saedi, et al.
Journal of Medicinal Chemistry|August 13, 2024
Discovery of Potent STT3A/B Inhibitors and Assessment of Their Multipathogen Antiviral Potential and SafetyJoseph E Pero, Elizabeth A Mueller, Ashley M Adams, et al.
Nature Cancer|November 18, 2021
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemiaMelissa B Pappalardi, Kathryn Keenan, Mark Cockerill, et al.
Pageof 4